Manulife (Manufacturers Life Insurance)’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-39,378
| Closed | -$165K | – | 3130 |
|
|
2023
Q1 | $165K | Hold |
39,378
| – | – | ﹤0.01% | 2629 |
|
|
2022
Q4 | $237K | Buy |
39,378
+1,652
| +4% | +$9.93K | ﹤0.01% | 2451 |
|
|
2022
Q3 | $220K | Sell |
37,726
-888
| -2% | -$5.17K | ﹤0.01% | 2525 |
|
|
2022
Q2 | $231K | Buy |
+38,614
| New | +$231K | ﹤0.01% | 2558 |
|
|
2018
Q3 | – | Sell |
-47,439
| Closed | -$236K | – | 4317 |
|
|
2018
Q2 | $236K | Buy |
47,439
+44,795
| +1,694% | +$223K | ﹤0.01% | 3002 |
|
|
2018
Q1 | $10K | Hold |
2,644
| – | – | ﹤0.01% | 3937 |
|
|
2017
Q4 | $7K | Buy |
2,644
+2,346
| +787% | +$6.21K | ﹤0.01% | 4088 |
|
|
2017
Q3 | $1K | Sell |
298
-433
| -59% | -$1.45K | ﹤0.01% | 4225 |
|
|
2017
Q2 | $2K | Buy |
731
+188
| +35% | +$514 | ﹤0.01% | 4180 |
|
|
2017
Q1 | $2K | Buy |
+543
| New | +$2K | ﹤0.01% | 3994 |
|
|
2016
Q4 | – | Sell |
-544
| Closed | -$2K | – | 4587 |
|
|
2016
Q3 | $2K | Hold |
544
| – | – | ﹤0.01% | 4106 |
|
|
2016
Q2 | $2K | Sell |
544
-14,016
| -96% | -$51.5K | ﹤0.01% | 4061 |
|
|
2016
Q1 | $75K | Buy |
14,560
+3,167
| +28% | +$16.3K | ﹤0.01% | 3171 |
|
|
2015
Q4 | $141 | Buy |
11,393
+390
| +4% | +$5 | ﹤0.01% | 2915 |
|
|
2015
Q3 | $161 | Buy |
11,003
+267
| +2% | +$4 | ﹤0.01% | 2825 |
|
|
2015
Q2 | $209 | Buy |
10,736
+692
| +7% | +$13 | ﹤0.01% | 2813 |
|
|
2015
Q1 | $182 | Buy |
10,044
+346
| +4% | +$6 | ﹤0.01% | 2801 |
|
|
2014
Q4 | $229 | Buy |
9,698
+962
| +11% | +$23 | ﹤0.01% | 2555 |
|
|
2014
Q3 | $211 | Sell |
8,736
-85
| -1% | -$2 | ﹤0.01% | 2607 |
|
|
2014
Q2 | $248K | Sell |
8,821
-1,066
| -11% | -$30K | ﹤0.01% | 2565 |
|
|
2014
Q1 | $337 | Buy |
9,887
+618
| +7% | +$21 | ﹤0.01% | 2348 |
|
|
2013
Q4 | $178 | Sell |
9,269
-666
| -7% | -$13 | ﹤0.01% | 2793 |
|
|
2013
Q3 | $163 | Buy |
9,935
+112
| +1% | +$2 | ﹤0.01% | 2807 |
|
|
2013
Q2 | $103K | Buy |
+9,823
| New | +$103K | ﹤0.01% | 3002 |
|